Literature DB >> 28577753

Cocaine-Induced Chromatin Modifications Associate With Increased Expression and Three-Dimensional Looping of Auts2.

Olivia Engmann1, Benoit Labonté1, Amanda Mitchell2, Pavel Bashtrykov3, Erin S Calipari1, Chaggai Rosenbluh4, Yong-Hwee E Loh1, Deena M Walker1, Dominika Burek1, Peter J Hamilton1, Orna Issler1, Rachael L Neve5, Gustavo Turecki6, Yasmin Hurd2, Andrew Chess4, Li Shen1, Isabelle Mansuy7, Albert Jeltsch3, Schahram Akbarian2, Eric J Nestler8.   

Abstract

BACKGROUND: Exposure to drugs of abuse alters the epigenetic landscape of the brain's reward regions, such as the nucleus accumbens. We investigated how combinations of chromatin modifications affect genes that regulate responses to cocaine. We focused on Auts2, a gene linked to human evolution and cognitive disorders, which displays strong clustering of cocaine-induced chromatin modifications in this brain region.
METHODS: We combined chromosome conformation capture, circularized chromosome conformation capture, and related approaches with behavioral paradigms relevant to cocaine phenotypes. Cell type-specific functions were assessed by fluorescence-activated cell sorting and viral-mediated overexpression in Cre-dependent mouse lines.
RESULTS: We observed that Auts2 gene expression is increased by repeated cocaine administration specifically in D2-type medium spiny neurons in the nucleus accumbens, an effect seen in male but not female mice. Auts2 messenger RNA expression was also upregulated postmortem in the nucleus accumbens of male human cocaine addicts. We obtained evidence that chromosomal looping, bypassing 1524 kb of linear genome, connects Auts2 to the Caln1 gene locus under baseline conditions. This looping was disrupted after repeated cocaine exposure, resulting in increased expression of both genes in D2-type medium spiny neurons. Cocaine exposure reduces binding of CCCTC-binding factor, a chromosomal scaffolding protein, and increases histone and DNA methylation at the Auts-Caln1 loop base in the nucleus accumbens. Cell type-specific overexpression of Auts2 or Caln1 in D2-type medium spiny neurons demonstrated that both genes promote cocaine reward.
CONCLUSIONS: These findings suggest that cocaine-induced alterations of neuronal three-dimensional genome organization destabilize higher order chromatin at specific loci that regulate responses to the drug.
Copyright © 2017 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; CTCF; Chromatin looping; DNA methylation; Histone methylation; Nucleus accumbens

Mesh:

Substances:

Year:  2017        PMID: 28577753      PMCID: PMC5671915          DOI: 10.1016/j.biopsych.2017.04.013

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  38 in total

1.  Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

Review 2.  Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data.

Authors:  Job Dekker; Marc A Marti-Renom; Leonid A Mirny
Journal:  Nat Rev Genet       Date:  2013-05-09       Impact factor: 53.242

3.  Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter.

Authors:  Erin S Calipari; Mark J Ferris; Cody A Siciliano; Benjamin A Zimmer; Sara R Jones
Journal:  J Pharmacol Exp Ther       Date:  2014-02-24       Impact factor: 4.030

Review 4.  CTCF: an architectural protein bridging genome topology and function.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2014-03-11       Impact factor: 53.242

Review 5.  The future of neuroepigenetics in the human brain.

Authors:  Amanda Mitchell; Panos Roussos; Cyril Peter; Nadejda Tsankova; Schahram Akbarian
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

6.  Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins.

Authors:  Razia Sultana; Chang-En Yu; Jun Yu; Jeffery Munson; Donghui Chen; Wenhui Hua; Annette Estes; Fanny Cortes; Flora de la Barra; Dongmei Yu; Syed T Haider; Barbara J Trask; Eric D Green; Wendy H Raskind; Christine M Disteche; Ellen Wijsman; Geraldine Dawson; Daniel R Storm; Gerard D Schellenberg; Enrique C Villacres
Journal:  Genomics       Date:  2002-08       Impact factor: 5.736

7.  Separable roles of the nucleus accumbens core and shell in context- and cue-induced alcohol-seeking.

Authors:  Nadia Chaudhri; Lacey L Sahuque; William W Schairer; Patricia H Janak
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

8.  A translational profiling approach for the molecular characterization of CNS cell types.

Authors:  Myriam Heiman; Anne Schaefer; Shiaoching Gong; Jayms D Peterson; Michelle Day; Keri E Ramsey; Mayte Suárez-Fariñas; Cordelia Schwarz; Dietrich A Stephan; D James Surmeier; Paul Greengard; Nathaniel Heintz
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

Review 9.  The dynamic architectural and epigenetic nuclear landscape: developing the genomic almanac of biology and disease.

Authors:  Phillip W L Tai; Sayyed K Zaidi; Hai Wu; Rodrigo A Grandy; Martin Montecino; André J van Wijnen; Jane B Lian; Gary S Stein; Janet L Stein
Journal:  J Cell Physiol       Date:  2014-06       Impact factor: 6.384

10.  Nucleus Accumbens Core and Shell Differentially Encode Reward-Associated Cues after Reinforcer Devaluation.

Authors:  Elizabeth A West; Regina M Carelli
Journal:  J Neurosci       Date:  2016-01-27       Impact factor: 6.167

View more
  21 in total

Review 1.  The Molecular Basis of Drug Addiction: Linking Epigenetic to Synaptic and Circuit Mechanisms.

Authors:  Eric J Nestler; Christian Lüscher
Journal:  Neuron       Date:  2019-04-03       Impact factor: 17.173

Review 2.  In vivo locus-specific editing of the neuroepigenome.

Authors:  Yun Young Yim; Collin D Teague; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2020-07-23       Impact factor: 34.870

Review 3.  The emerging roles for the chromatin structure regulators CTCF and cohesin in neurodevelopment and behavior.

Authors:  Liron Davis; Itay Onn; Evan Elliott
Journal:  Cell Mol Life Sci       Date:  2017-11-06       Impact factor: 9.261

4.  Viral Expression of Epigenome Editing Tools in Rodent Brain Using Stereotaxic Surgery Techniques.

Authors:  Peter J Hamilton; Carissa J Lim; Eric J Nestler; Elizabeth A Heller
Journal:  Methods Mol Biol       Date:  2018

Review 5.  Three-dimensional chromosome architecture and drug addiction.

Authors:  Javed M Chitaman; Peter Fraser; Jian Feng
Journal:  Curr Opin Neurobiol       Date:  2019-07-02       Impact factor: 6.627

Review 6.  Spatial genome exploration in the context of cognitive and neurological disease.

Authors:  Prashanth Rajarajan; Tyler Borrman; Will Liao; Sergio Espeso-Gil; Sandhya Chandrasekaran; Yan Jiang; Zhiping Weng; Kristen J Brennand; Schahram Akbarian
Journal:  Curr Opin Neurobiol       Date:  2019-06-27       Impact factor: 6.627

7.  Mechanisms underlying microRNA-222-3p modulation of methamphetamine-induced conditioned place preference in the nucleus accumbens in mice.

Authors:  Qing Shang; Jing Wang; Zhijia Xi; Baoyao Gao; Hongyan Qian; Ran An; Gaojie Shao; Hua Liu; Tao Li; Xinshe Liu
Journal:  Psychopharmacology (Berl)       Date:  2022-07-26       Impact factor: 4.415

Review 8.  How the epigenome integrates information and reshapes the synapse.

Authors:  Rianne R Campbell; Marcelo A Wood
Journal:  Nat Rev Neurosci       Date:  2019-03       Impact factor: 34.870

9.  Exposure to drugs of abuse induce effects that persist across generations.

Authors:  Annalisa M Baratta; Richa S Rathod; Sonja L Plasil; Amit Seth; Gregg E Homanics
Journal:  Int Rev Neurobiol       Date:  2020-09-30       Impact factor: 3.230

Review 10.  Epigenetics of Drug Addiction.

Authors:  Andrew F Stewart; Sasha L Fulton; Ian Maze
Journal:  Cold Spring Harb Perspect Med       Date:  2021-07-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.